Nearly 1 in 10 lupus patients also develop pulmonary arterial hypertension (PAH), a condition where the blood pressure…
Iqra Mumal, MSc
Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Iqra Mumal, MSc
The United Kingdom’s first set of guidelines for care of patients with systemic lupus erythematosus (SLE) has been published by…
Poverty is associated with an accumulation of lupus damage, which leads to a higher risk of death, a study reports. The…
Patients who have their lupus treated at more than one care facility are at higher risk of developing severe infections…
The presence of anti-SS-B autoantibodies alone was not associated with connective tissue disease (CTD) in daily clinical practice, particularly in…
The lectin pathway of the complement system — a system that enhances the body’s ability to clear invaders — may…
Women who experience trauma or have post-traumatic stress disorder are at higher risk of developing systemic lupus erythematosus, a study…
Uptravi (selexipag) delays the progression of pulmonary arterial hypertension in people with PAH that is associated with connective tissue diseases,…
Sufficient scientific evidence exists to support the switch from bio-originators to biosimilars to treat rheumatic diseases, concluded a task force…
The Montreal Cognitive Assessment (MoCA) may be a useful clinical tool for screening cognitive impairment in patients with systemic lupus…